ReviewFrontiers in neuroscience2016

Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders.

Gemma Navarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.